Find Your Broker
Share Name Share Symbol Market Type Share ISIN Share Description
Fenner LSE:FENR London Ordinary Share GB0003345054 ORD 25P
  Price Change % Change Share Price Shares Traded Last Trade
  +0.00p +0.00% 609.00p 0 05:00:01
Bid Price Offer Price High Price Low Price Open Price
609.00p 609.50p - - -
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Industrial Engineering 655.40 38.10 17.60 34.6 1,181.5

Fenner (FENR) Latest News

More Fenner News
Fenner Takeover Rumours

Fenner (FENR) Share Charts

1 Year Fenner Chart

1 Year Fenner Chart

1 Month Fenner Chart

1 Month Fenner Chart

Intraday Fenner Chart

Intraday Fenner Chart

Fenner (FENR) Discussions and Chat

Fenner (FENR) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Fenner trades in real-time

Fenner (FENR) Top Chat Posts

DateSubject
20/3/2018
11:44
meijiman: If the approach had been from one of the other main players in belting then I would see the share price rising higher than 610p. As it is I can't see anyone wanting to take on Michelin..but who knows.Someone obviously feels its worth a punt north of 610p but not me.
20/12/2017
15:18
lauders: I note that Low & Bonar haven't exactly taken the news well share price-wise! Thought with the track record being highlighted here today they would have gone the opposite way. Still I am sure FENR must have done "just a bit" of due diligence and have their reasons for offering him the position.
20/12/2017
08:10
davr0s: So we've acquired a new CEO whose just left his last company with a profit warning and a 20% share price drop. Opening market doesn't look that impressed - sure they could have managed the timing of the announcement better. Hope he does a better job here
23/11/2017
01:05
lauders: Courtesy of Apad on the VLG BB: Https://www.sharescope.co.uk/philoakley_article182.jsp As you can see, analysts are already predicting a fairly rosy outlook for profits. The shares are also quite highly valued on a one year forecast rolling PE of just over 18 times at 389p. However, the operational gearing is so big with this company that it won't take much in the way of a trading improvement to feed through into more forecast upgrades. This could possibly lead to further share price upside in the short run. The problem with operational gearing is that it works in both upwards and downwards direction. Given Fenner's still large exposure to commodity prices in both conveyor belting and AEP this would make me nervous owning the shares as a long-term investment at the current share price. For me, the non-cyclical parts of AEP such as medical are not yet big enough to offset the big risk of getting badly burned when commodity cycles turn downwards. This leads me to view the shares as of more interest to traders than investors at the moment. This is a shame, as I think there is a lot to like about this company. So more of a traders share than one for the long term investor is Phil's take. Just posting for interest as quite a lot of detail. You will have to make your own mind up about the future. It has already risen above the price at the time of writing the article.
16/11/2017
01:50
lauders: TMF but still worth a read: Http://www.fool.co.uk/investing/2017/11/15/one-stunning-growth-stock-id-buy-alongside-fevertree-drinks-plc/ Of course, we live in a politically and economically uncertain world, but I’m encouraged by Fenner’s progress and delighted that the directors now expect next year’s trading to come in “above its previous expectations,” a phrase that’s music to the ears of investors far and wide. At a share price near 364p, Fenner trades on a forward price-to-earnings (P/E) ratio of almost 19 for the current trading year to August 2018, not cheap, but fair for a company performing so well. I think the firm is well worth your further research and the stock could make for a more comfortable hold than, for example, Fevertree Drinks (LSE: FEVR), which has a stratospheric valuation.
07/7/2017
06:44
lauders: Trading update looks excellent to me. Watch the share price drop now LOL! Very happy to keep holding here.
07/9/2016
13:08
lauders: Fenner dividend paid today as well, so a good movement in the share price and a dividend. Double joy LOL!
29/2/2016
11:33
meijiman: Can't see it though with all that exposure to coal. Belts need replacing but if profits are so low then companies might hold off from buying new belts.This company never changes. Shares go up with the commodity cycle-the company then puffs away about the higher quality earnings. Sure enough the commodity cycle turns down and the profits collapse and the share price tanks.
17/5/2015
01:57
lauders: Well I hope I timed my small purchase well here. In at 221p (inc costs) and hoping that things have improved for FENR since these words were stated in the half year report: Outlook and dividend AEP's industrial, medical and other non-oil speciality polymer businesses, which account for some 70 per cent of AEP's revenue, are expected to continue to perform well. The financial results for the second half of the year will also benefit from the acquisition of Charter Medical which took place towards the end of the first half of the year. The remainder of AEP is seeing an impact from lower levels of activity in the oil & gas industry as a result of sharply reduced oil and gas prices. Order intake started to decline in February; the timing and extent of the decline are within the range of our planning assumptions. ECS expects to see a continuation of the difficult trading conditions across all of its regions which is being taken into account in managing the division's cost base. In the USA, the outlook for coal prices and consumption appears to have weakened whilst in Australia, lower demand for belting products and services is expected to exacerbate the impact of continuing pricing pressure. In EMEA, any recovery in Europe is expected to be slow, and newer mining markets are expected to remain under pressure. In response to the trading conditions being faced, cash overheads across the Group have been reduced by an annualised £9m with effect from the start of the second half of the year. The Group will continue to closely manage all aspects of its costs and cash flow and has recently announced that it will begin a process of consultation about a significant retrenchment at the ECS operation in the UK, which currently employs 127 people. By the end of the financial year, the major capital expenditure projects in AEP are expected to be substantially complete. Going forwards, the Group can comfortably maintain capital expenditure below the level of the depreciation charge whilst still investing in the future growth of AEP. Taking into account the management actions we are taking in response to the trading conditions, the Board's expectations for the outcome for the year remain substantially unchanged overall. An unchanged interim dividend of 4.0p per share has been declared, which will be paid on 7 September 2015 to shareholders on the register on 31 July 2015. If the improving environment for oil is reflected in the business here then we may quickly return to some of the previous director buy levels of 250p+. I like the acquisition too. Medical businesses are always good revenue generators depending on product and need. FENR has a few so many avenues & sources of income. The products Charter Medical sell look like they are needed to me: hTTp://www.chartermedical.com/index.html On the same path Secant Medical also looks like a winner with its bioresorbable Regenerez® technology as discussed here: hTTp://www.plasticstoday.com/articles/Bioresorbable-technology-Secant-Medical-addresses-limitations-PLA-PGA-150126 This older article shows the potential market for such materials too (interesting facts in the 1st paragraph): hTTp://www.qmed.com/mpmn/article/biomaterials-step-21st-century. Likewise Xeridiem sells everyday products needed by the medical community ( hTTp://xeridiem.com/ ). Like the positive report here for instance: hTTp://www.mddionline.com/article/partnership-cardiac-device-development-pays So as well as the other businesses I like FENR solely for the medical side and hope that progress made in future will be reflected in the share price. Thanks to CR for highlighting FENR on his board and consistently mentioning them. Thought they were worth a further look based on his constant "belief" in a re-rating here :-)
26/9/2006
08:26
petersinthemarket: I took a look at the relationship between the dollar/sterling exchange rate and the FENR share price last night. There must be a relationship, and the obvious intention is to see if a combined chart would aid reasonably reliable prediction of FENR share price movements. I manually laid the last 6mths Ex rate curve on top of a 6mths FENR share price chart. The two curves seemed to generally track each other up and down fairly closely. If anything, the share price seems to rise and fall with a slight lag against the rate changes, but occasionally the curves diverge quite markedly. Has anyone else studied this relationship, preferably a bit more professionally? Also does anyone know how we can combine two charts automatically and over a much longer period. It occurs to me there might be a relationship with the oil price too.
Fenner share price data is direct from the London Stock Exchange
Your Recent History
LSE
FENR
Fenner
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20181210 15:32:12